GeneDx Holdings (WGS) reported a Q1 loss Wednesday of $0.23 per share, narrowing from a loss of $0.78 a year earlier.
Two analysts polled by FactSet expected a loss of $0.27 per share.
Revenue for the quarter ended March 31 was $87.1 million, up from $62.4 million a year earlier.
Analysts surveyed by FactSet expected $79.5 million.
The company said it now expects full-year revenue of $360 million to $375 million compared with its prior guidance of $350 million to $360 million. Analysts polled by FactSet expect $358.9 million.
Shares of the company were down more than 27% in recent Wednesday premarket activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。